DDC

DDC Enterprise Limited Reports on NYSE American Noncompliance Notice

Retrieved on: 
tisdag, maj 21, 2024
Security (finance), Exchange, Bank statement, DDC, Form, Annual report, File, Medical device

NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- DDC ENTERPRISE LIMITED (NYSE AMERICAN: DDC) (“DAYDAYCOOK” OR THE “COMPANY”) announced today that on May 16, 2024, the Company received a written notice from NYSE Regulation (the “NYSE Notice”) stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (“NYSE American”, or the “Exchange”) under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the “Company Guide”) because the Company failed to timely file with the Securities and Exchange Commission (the “SEC”) its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 Form 20-F”), which was due on May 15, 2024 (the “Filing Delinquency”).

Key Points: 
  • NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- DDC ENTERPRISE LIMITED (NYSE AMERICAN: DDC) (“DAYDAYCOOK” OR THE “COMPANY”) announced today that on May 16, 2024, the Company received a written notice from NYSE Regulation (the “NYSE Notice”) stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (“NYSE American”, or the “Exchange”) under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the “Company Guide”) because the Company failed to timely file with the Securities and Exchange Commission (the “SEC”) its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 Form 20-F”), which was due on May 15, 2024 (the “Filing Delinquency”).
  • If the Company fails to file the 2023 Form 20-F during the Initial Cure Period, the Exchange may, in its sole discretion, grant an up to six-month additional cure period (the “Additional Cure Period”).
  • The Company is making all efforts to file the 2023 Form 20-F as soon as possible and in any event within the six-month Initial Cure Period.
  • The NYSE Notice does not affect the Company’s business operations or its reporting obligations under the Securities and Exchange Commission regulations and rules.

Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
tisdag, maj 14, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Insurance, Patient, Ovarian cancer, Food, FDA, Marketing, NSCLC, DDC, PROC, Research, Pancreatic cancer, Cancer, Acquisition, Sjögren, Food and Drug Administration, NUVB, Pharmaceutical industry

Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.

Key Points: 
  • Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the first quarter ended March 31, 2024, and provided a business update.
  • “The first quarter of 2024 included multiple significant events for Nuvation Bio.
  • As of March 31, 2024, Nuvation Bio had cash, cash equivalents and marketable securities of $597.0 million.
  • For the three months ended March 31, 2024, Nuvation Bio reported a net loss of $14.8 million, or $(0.07) per share.

GXO to Manage Logistics Operations for Levi Strauss & Co at State-of-the-Art German Distribution Center

Retrieved on: 
måndag, maj 6, 2024
DTC, DIY, BASF, DDC, Biophysical environment, Partnership, Digital, FMCG, Senior, LEED, Levi Strauss & Co., GXO, WELL, OBI, Growth, Warehouse

DORSTEN, Germany and GREENWICH, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced a 20-year partnership agreement with Levi Strauss & Co (LS&Co.) to manage operations at a state-of-the-art 70,000 square meter Dorsten Distribution Center (DDC) launching in early June. GXO will manage all logistics services for LS&Co. at the fully-automated facility, including value-added services, to distribute apparel and accessories across wholesale, retail, digital, ecommerce and marketplace channels.

Key Points: 
  • to manage operations at a state-of-the-art 70,000 square meter Dorsten Distribution Center (DDC) launching in early June.
  • GXO will manage all logistics services for LS&Co.
  • at the fully-automated facility, including value-added services, to distribute apparel and accessories across wholesale, retail, digital, ecommerce and marketplace channels.
  • This fully-automated site is among the greenest distribution centers in all of Europe with phenomenal sustainability features that raise the bar in the logistics industry.

The DDC Group Appoints WNS' Nimesh Akhauri as New Group CEO

Retrieved on: 
tisdag, april 30, 2024
WNS, ITC, AI, DDC, Capgemini, BPO, QMS, Intellectual property, Delivery, Growth, Management

EVERGREEN, Colo., April 30, 2024 /PRNewswire/ -- The DDC Group, a pioneer in data solutions and leading provider in business process outsourcing (BPO) and technology, is pleased to announce the appointment of Nimesh Akhauri as its new Group Chief Executive Officer (CEO), effective May 1, 2024. Group CEO predecessor and Co-founder Jan Trevalyan, who has stood at the helm for the past 35 years, will assume the esteemed position of Chairman of the Board.

Key Points: 
  • Founded in 1989 as one of the world's first BPO companies, The DDC Group has consistently set industry standards, delivering exceptional value to its clients worldwide under Trevalyan's visionary leadership.
  • The esteemed Co-founder and outgoing CEO has led The DDC Group with vision and dedication for the past 35 years.
  • "It is an honor to join The DDC Group at such an exciting time in its journey," remarked Akhauri.
  • As The DDC Group embraces the future with enthusiasm, the company remains steadfast in its dedication to creating data-driven, goal-oriented solutions that deliver unmatched customer satisfaction.

The DDC Group Appoints WNS' Nimesh Akhauri as New Group CEO

Retrieved on: 
tisdag, april 30, 2024
WNS, ITC, AI, DDC, Capgemini, BPO, QMS, Intellectual property, Delivery, Growth, Management

EVERGREEN, Colo., April 30, 2024 /PRNewswire/ -- The DDC Group, a pioneer in data solutions and leading provider in business process outsourcing (BPO) and technology, is pleased to announce the appointment of Nimesh Akhauri as its new Group Chief Executive Officer (CEO), effective May 1, 2024. Group CEO predecessor and Co-founder Jan Trevalyan, who has stood at the helm for the past 35 years, will assume the esteemed position of Chairman of the Board.

Key Points: 
  • The DDC Group extends heartfelt gratitude to Trevalyan.
  • The esteemed Co-founder and outgoing CEO has led The DDC Group with vision and dedication for the past 35 years.
  • "It is an honor to join The DDC Group at such an exciting time in its journey," remarked Akhauri.
  • As The DDC Group embraces the future with enthusiasm, the company remains steadfast in its dedication to creating data-driven, goal-oriented solutions that deliver unmatched customer satisfaction.

Novotech Appoints Commercial and Clinical Life Sciences Specialist to Head Up Global Drug Development Consulting Team

Retrieved on: 
torsdag, maj 2, 2024
Contract research organization, University, Probability, Public health, DDC, Vaccine, Therapy, CMC, Drug development, Antibody, Toxicology

BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- Novotech , the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC) .

Key Points: 
  • BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- Novotech , the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has appointed Scott Schliebner as Vice President and Global Head, Drug Development Consulting (DDC) .
  • He is a proven strategic, innovative, and business focused life sciences executive with ~30 year of experience across the biopharma and CRO sectors.
  • To do this, DDC leverages CMC/manufacturing, toxicology, clinical/medical and regulatory affairs experts with extensive industry experience covering all phases ​of drug development.
  • I am also passionate about leveraging data and technology including RWE/RWD, technological innovation, and patient-focused paradigms to accelerate clinical drug development,” he said.

DayDayCook to Present at the Planet MicroCap Showcase: Vegas 2024

Retrieved on: 
tisdag, april 23, 2024
DDC, Planet, Paris Las Vegas, Indian stock exchange

NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- DDC Enterprise, Ltd., (NYSEAM: DDC) (“DayDayCook,” “DDC,” or the “Company”), a leading content-driven food consumer brand, today announces that Kyle Guse, Chief Legal Officer & Head of IR, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.

Key Points: 
  • NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- DDC Enterprise, Ltd., (NYSEAM: DDC) (“DayDayCook,” “DDC,” or the “Company”), a leading content-driven food consumer brand, today announces that Kyle Guse, Chief Legal Officer & Head of IR, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.
  • The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV.

Automotive-Compliant Video Switch from Diodes Incorporated Cuts Bill of Materials for Leading Interface Standards

Retrieved on: 
tisdag, april 30, 2024
Technology, General Automotive, Mobile, Wireless, Audio, Video, Automotive, Other Technology, Networks, Internet, Hardware, Electronic Design Automation, Semiconductor, Data Management, Security, Consumer Electronics, PCB, LVDS, HPD, DDC, HDMI, DIOD, ADAS, AUX, DisplayPort, Sunlight, AC, PPAP, USB, IATF

Diodes Incorporated (Diodes) (Nasdaq: DIOD) has introduced the PI3WVR14412Q , an automotive-compliant* 20Gbps 1:2 video switch for in-cabin infotainment and advanced driver assistance systems (ADAS) applications.

Key Points: 
  • Diodes Incorporated (Diodes) (Nasdaq: DIOD) has introduced the PI3WVR14412Q , an automotive-compliant* 20Gbps 1:2 video switch for in-cabin infotainment and advanced driver assistance systems (ADAS) applications.
  • The switch has four high-speed lanes with a 10GHz bandwidth to handle DisplayPort™ 2.1, HDMI™ 2.1, MIPI® DPHY/CPHY, USB 3.2, and LVDS connections.
  • In addition, there are switches for hot-plug detect (HPD), HDMI display data channel (DDC), and DisplayPort auxiliary (AUX) signals.
  • The wide ambient operating-temperature range, from -40°C to 105°C, permits deployment in challenging environments or locations exposed to direct sunlight.

Crucial Data Solutions Introduces TrialKit PACS to Streamline Image Management in Clinical Trials

Retrieved on: 
tisdag, april 23, 2024
Research, Technology, Clinical Trials, Health Technology, Software, Biotechnology, Internet, Health, Data Management, Science, Radiology, DICOM, DDC, EHR, EDC, ChromeOS, PHI, PACS, CDS, Data collection, MRI, Clinical trial, Control, Medical imaging

Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .

Key Points: 
  • Crucial Data Solutions (CDS), a leading provider of data collection and trial management software to advance clinical research, today announced the launch of TrialKit PACS .
  • This innovative solution streamlines medical image management within clinical trials, offering a unified platform for all data collection and management needs.
  • TrialKit PACS streamlines medical image capture into EDC trials by eliminating the time and cost of third party systems licensing and integration.
  • Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative data collection and clinical trial management technology on the market today.

The DDC Group Adds Nearshore Outsourcing Locations in Central America and South America

Retrieved on: 
torsdag, april 11, 2024
Carbon, Netcom, Social media, DDC, Customer service, Partnership, VIP, ISO, Human

EVERGREEN, Colo., April 11, 2024 /PRNewswire/ -- Global business process outsourcing and technology leader The DDC Group today announced it is adding Central America and South America to its worldwide footprint of strategic operating locations.

Key Points: 
  • EVERGREEN, Colo., April 11, 2024 /PRNewswire/ -- Global business process outsourcing and technology leader The DDC Group today announced it is adding Central America and South America to its worldwide footprint of strategic operating locations.
  • The DDC Group adds nearshore services for North American clients through a strategic partnership with Netcom BCC.
  • "Netcom provides a well-established, technically advanced and highly secure foundation with an expert talent pool across Central America and South America," said Jan Trevalyan, Group CEO of The DDC Group.
  • "With high standards and core values aligned with our own, we are excited to grow as a part of The DDC Group," said Murillo.